source
- Novo Nordisk cuts 13,000 jobs to redirect funds toward R&DNovo Nordisk announced further workforce reductions, bringing total departures to about 13,000 over the past year. CEO Maziar Mike Doustdar said the cuts are intended to free up capital for resear…
- Boehringer Ingelheim to invest up to $1B in AI-driven solid tumor partnership with EnvisagenicsBoehringer Ingelheim announced a partnership with Envisagenics to develop precision oncology therapies that use artificial intelligence to identify cancer-specific RNA splicing alterations. The co…